ETF Research Center

Global X Longevity Thematic ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to track the performance of the Indxx Global Longevity Thematic Index.

FUND BASICS
Category	Global Equities
Fund Sponsor	Global X
Website	www.globalxfunds.com
Inception date	May 10, 2016
Assets (mns)	$24
Currency	USD
Expense ratio	50 bp
Distributions	Annually

FUND STRUCTURE
Regulation	Open-Ended Fund
Custodian
Weighting	Market Cap
Index replication
Uses derivatives	No
Options available	No

SECTOR BREAKDOWN

CONSTITUENT BREAKDOWN
No. of constituents	98
Wgt avg mkt cap (mns)	$45,863
Large cap (>$10bn)	76.6%
Mid cap ($2-10bn)	16.8%
Small cap (<$2bn)	5.6%
Developed mkts	98.1%
Emerging mkts	1.9%

TOP TEN HOLDINGS
Total	34.5 %
CHUGAI PHARMACEUTICAL CO LTD	4.0 %
EDWARDS LIFESCIENCES CORP	3.7 %
MEDTRONIC PLC	3.6 %
BIOGEN IDEC INC	3.6 %
BRISTOL-MYERS SQUIBB CO	3.6 %
AMGEN INC	3.4 %
VERTEX PHARMACEUTICALS INC	3.3 %
BOSTON SCIENTIFIC CORP	3.2 %
NOVO NORDISK A/S-B	3.1 %
ABBVIE INC	3.0 %

TOP COUNTRY EXPOSURE
	UNITED STATES	64.7 %
	JAPAN	7.5 %
	DENMARK	6.1 %
	IRELAND	4.3 %
	BRITAIN	3.0 %
	SWITZERLAND	2.5 %
	FRANCE	1.9 %
	GERMANY	1.9 %
	SOUTH KOREA	1.7 %
	BELGIUM	1.3 %

HISTORICAL PERFORMANCE info

	Custom date range	Compare to
	thru

Standardized Annual Returns (thru November 30)
Year-to-date	1 year	5 years	10 years	Since Incep.
25.4%	15.7%	--	--	13.6%

Market Correlations
versus...	Beta	R-squared
S&P500	0.94	61%
MSCI EAFE	0.85	42%
MSCI Emg. Mkts.	0.65	39%

Technical Indicators
Recent close	$23.69
30d moving avg.	$23.03
Annualized volatility	14.5%
Short interest (ETF)	1.0%
Relative strength (RSI)	70

Liquidity measures
Avg. volume (thou.)	3
Turnover	0.3%
Bid/Ask (% of price)	1.22%
ADV underlying (mns)	$10,604

Distributions

FINDING ALTERNATIVE FUNDS

Below is a list of 20 potential alternatives to the Global X Longevity Thematic ETF based on the alternatives' overlap in portfolio holdings with LNGR. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker:

LNGR

Expense:

50 bp

ALTAR Score™:

3.3%

ALTERNATIVE ETFs BASED ON OVERLAP WITH LNGR
Ticker	Fund Name	Overlap¹ vs LNGR (%)	Expense ratio (bp)	Savings vs LNGR (bp)	ALTAR Score™ (%)	ALTAR vs LNGR (%)
RYH	Invesco S&P Equal Weight Healthcare	29.1	40	10	7.0	+3.7
IYH	iShares US Healthcare	29.0	43	7	6.3	+2.9
FHLC	Fidelity MSCI Health Care	28.2	8	42	5.8	+2.5
GDNA	Goldman Sachs Motif Human Evolution	27.4	50	0	1.0	-2.3
XLV	Health Care Select Sector SPDR	27.4	13	37	7.2	+3.9
VHT	Vanguard Health Care	27.0	10	40	5.9	+2.6
IEIH	iShares Evolved U.S. Innovative Healthcare	26.2	18	32	4.4	+1.1
JHMH	John Hancock Multifactor Health Care	26.1	40	10	6.6	+3.3
IHI	iShares DJ US Medical Devices	25.2	43	7	3.8	+0.5
IEHS	iShares Evolved U.S. Healthcare Staples	24.8	18	32	5.9	+2.6
IBB	iShares NASDAQ Biotechnology	23.2	47	3	0.4	-2.9
IXJ	iShares S&P Global Healthcare	23.1	46	4	6.4	+3.0
FXH	First Trust Health Care Alphadex	21.9	63	-13	7.1	+3.7
HTEC	Robo Global Healthcare Technology and Innovation	20.1	68	-18	-0.0	-3.4
FBT	First Trust NYSE-ARCA Biotechnology	19.7	57	-7	-0.7	-4.1
XHE	SPDR S&P Health Care Equipment	19.5	35	15	2.1	-1.2
BBH	VanEck Vectors Biotech	19.2	35	15	4.5	+1.2
XBI	SPDR S&P Biotech ETF	18.6	35	15	-4.4	-7.8
BBP	BioShares Biotech Products	16.0	79	-29	-3.7	-7.0
PJP	Invesco Dynamic Pharmaceuticals	16.0	56	-6	9.4	+6.1

¹Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

	2014	2015	2016	2017	2018	2019E	2020E
Sales per share	**	**	**	**	**	**	**
Earnings per share	**	**	**	**	**	**	**
Dividends per share	**	**	**	**	**	**	**
Book value per share	**	**	**	**	**	**	**

Sales per share growth		**%	**%	**%	**%	**%	**%
EPS growth		**%	**%	**%	**%	**%	**%

Sales per share growth		**%	**%	**%	**%	**%	**%
EPS growth		**%	**%	**%	**%	**%	**%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est.	**%		Debt-to-equity	**x
Asset turnover	**%		Assets-to-equity	**x

Return on equity

Revision activity*

*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS

	2018	2019E	2020E
Price-to-sales	**	**	**
Price-to-earnings	**	**	**
Price-to-cash flow	**	**	**
Price-to-growth	**	**	**
Price-to-book value	**	**	**
Yield	**	**	**

Historical valuation trends

Forward multiple:	Global X Longevity Thematic
Relative to:	S&P500	MSCI EAFE	MSCI Emg. Mkts.	Other ETF:

UNDERWEIGHT

Below average appreciation potential. A rating of UNDERWEIGHT is assigned to ETFs with ALTAR Scores in the 2nd quintile (ranking higher than only 20%-40%) of their category. Typically, funds in this category consist of stocks trading at relatively expensive valuations and/or having below-average fundamentals.

ALTAR Score™

Calculation of ALTAR Score™
Avg. Return on Equity	13.6	%
Divided by: Fwd. P/BV	3.6	x
Less: Expense ratio	50	bp
Equals: ALTAR Score	3.3	%

More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS

COMPOSITE RATING	1.55	CATEGORY AVERAGE	1.55

The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale: BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3. Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.